TheProfitWatch

PASG - Passage Bio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.29 0.32 (4.39%) --- 0.0 (0.0%) -0.2 (-2.56%) --- 0.32 (4.39%) 0.0 (0.0%) 0.0 (0.0%)

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.96
Diluted EPS:
-2.96
Basic P/E:
-2.5709
Diluted P/E:
-2.5709
RSI(14) 1m:
100.0
VWAP:
7.61
RVol:

Events

Period Kind Movement Occurred At

Related News